TipRanks
Go Ultimate55% OFF

BioInvent International AB (BINV) Stock Forecast & Price Target

2 Followers
See the Price Targets and Ratings of:

BINV Analyst Ratings

Hold
1Ratings
0Buy1Hold0Sell
Based on 1 analysts giving stock ratings to BioInvent International AB in the past 3 months

BINV Stock 12 Month Forecast

There are no analyst price targets in the last 3 months.

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for SE:BINV
Price TargetFollowArticle
Pareto Analyst forecast on SE:BINVUnknown AnalystNot RankedPareto―hold―Downgraded11/03/26
Stifel NicolausSEK 90buy2410.46%UpsideReiterated05/22/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AXGNAxoGen
SLDBSolid Biosciences
AHCOAdaptHealth
ONCBeOne Medicines
ARDXArdelyx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering BioInvent International AB

3 Months
Oscar Haffen Lamm
Oscar Haffen LammStifel Nicolaus
Success Rate0/2 ratings generated profit
0%
Average Return
0.00%

Copying Oscar Haffen Lamm's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of 0.00% per trade.

1 Year
Oscar Haffen Lamm
Oscar Haffen LammStifel Nicolaus
Success Rate0/2 ratings generated profit
0%
Average Return
-43.90%

Copying Oscar Haffen Lamm's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -43.90% per trade.

2 Years
Oscar Haffen Lamm
Oscar Haffen LammStifel Nicolaus
Success Rate0/2 ratings generated profit
0%
Average Return
-87.80%

Copying Oscar Haffen Lamm's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -87.80% per trade.

BINV Analyst Recommendation Trends

00.511.52Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for BINV
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy10000
Buy00000
Hold00001
Sell00000
Strong Sell00000
total10001

In the current month, BINV has received 0 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. BINV average Analyst price target in the past 3 months is ―.

BINV Financial Forecast

SEK -3SEK -2.5SEK -2SEK -1.5SEK -1Q1 2026Q3 2026Q4 2026
HighSEK -1.07
ConsensusSEK -1.07
LowSEK -1.07

BINV Earnings Forecast

Next quarter’s earnings estimate for BINV is -SEK 1.07 with a range of -SEK 1.07 to -SEK 1.07. The previous quarter’s EPS was -SEK 1.81. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

SEK 3MSEK 5.6MSEK 8.2MSEK 10.8MSEK 13.4MQ1 2026Q3 2026Q4 2026
HighSEK 10M
ConsensusSEK 10M
LowSEK 10M

BINV Sales Forecast

Next quarter’s sales forecast for BINV is SEK 10.00M with a range of SEK 10.00M to SEK 10.00M. The previous quarter’s sales results were SEK 10.79M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

BINV Stock Forecast FAQ

Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is BioInvent International AB a Buy, Sell or Hold?
BioInvent International AB has a consensus rating of Hold, which is based on 0 buy ratings, 1 hold ratings and 0 sell ratings.
What do analysts say about BioInvent International AB?
BioInvent International AB’s analyst rating consensus is a Hold. This is based on the ratings of 1 Wall Street analysts.
How can I buy shares of BioInvent International AB?
To buy shares of SE:BINV, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.